Patient Advocates Tune in for Precision Medicine Primer Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers. by Kevin McLaughlin Immunotherapy Options for Breast Cancer Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions. by Anna Goshua Are Liquid Biopsies Ready for the Clinic? Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard. by Kendall K. Morgan Forward Look Scanning Disparities Whether lung cancer patients receive PET scans depends on race, according to a study. by Ashley P. Taylor Forward Look Doing More With Less Hypofractionation may allow patients to finish radiation treatment sooner. by Stephen Ornes Forward Look What’s Next? Using deep learning to detect tumor mutations. by Christina Bennett Multiple Myeloma: Choosing Your Path New therapies provide hope and options for people as they monitor and manage this incurable blood cancer. by Tara Haelle Physicians Underestimate Severity of Radiation Side Effects Breast cancer patients’ symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age. by Marci A. Landsmann Drug Dependence After Breast Surgery A study indicates that some breast cancer patients who receive mastectomy and reconstruction may be at risk of persistent drug use following surgery. by Marcus A. Banks Cancer Centers Cope With COVID-19 Surge Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge. by Ashley P. Taylor next Cancer Talk Survival Statistics 101 Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean. by Ashley P. Taylor Patient Advocates Tune in for Precision Medicine Primer Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers. by Kevin McLaughlin Testing COVID-19 Treatments for Patients With Cancer: An Ongoing Need Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus. by Marcus A. Banks Immunotherapy Options for Breast Cancer Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions. by Anna Goshua More Posts